Beijing Yuanxin Technology Group Co., Ltd.

北京圆心科技集团股份有限公司

Operates specialty pharmacies and internet hospitals in China, dispensing prescription and innovative drugs to patients, and provides full-chain commercialization services for pharmaceutical companies, including industry promotion, patient management and insurance-related payment solutions. Per the prospectus, the largest full-chain innovative drug commercialization service provider in China in 2024.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Supplier concentration
• Overlapping customers and suppliers
• Connected or related major customers / suppliers
• Distribution model
• Outsourced production (OEM / contract manufacturing)
• Business changes and acquisitions
• Losses and path to profitability
• Negative operating cash flow
• Working capital: receivables, prepayments and cash cycle
• Inventory level and ageing
• Goodwill, intangibles and asset impairment
• Investments and fair-value assets
• Non-IFRS measures and adjustments
• Related-party transactions and balances
• Material share-based payments